Shares of Health Care sector company Pfizer moved -0.1% today, and are now trading at a price of $35.59. The large-cap stock's daily volume was 11,652,453 compared to its average volume of 26,780,620. The S&P 500 index returned a -1.0% performance.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company is based in New York and has 83,000 full time employees. Its market capitalization is $200,916,582,400. Pfizer currently offers its equity investors a dividend that yields 4.5% per year.
22 analysts are following Pfizer and have set target prices ranging from $31.83 to $68.2 per share. On average, they have given the company a rating of buy. At today's prices, PFE is trading -14.49% away from its average analyst target price of $41.62 per share.
Over the last year, PFE shares have gone down by -27.0%, which represents a difference of -37.0% when compared to the S&P 500. The stock's 52 week high is $54.93 per share and its 52 week low is $35.35. With average free cash flows of $24.76 Billion that have been growing at an average rate of 22.1% over the last 4 years, Pfizer declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-23 | 29,267,000 | -3,236,000 | 32,503,000 | -7.9 |
| 2022-02-24 | 32,580,000 | -2,711,000 | 35,291,000 | 112.2 |
| 2021-02-25 | 14,405,000 | -2,226,000 | 16,631,000 | 13.65 |
| 2020-02-27 | 12,588,000 | -2,046,000 | 14,634,000 | n/a |
